Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Authors of a new study stress the need to improve access to cancer screenings, especially for minorities and lower-income populations.
Lung cancer patients had less depression and anxiety during the COVID-19 pandemic than their healthy counterparts.
New diagnoses of bladder, colorectal, lung and prostate cancer fell during the spring of 2020 and did not return to previous levels.
The World Trade Center dust plume exposed thousands to dangerous pollutants. Now the health consequences are clear.
But results from the Mass General Brigham system also found that racial and economic disparities remain for some tests.
The early cancer is detected, the easier it is to treat.
Studies have shown an alarming drop in screenings—and more advanced cancer—during the COVID-19 pandemic.
The coronavirus vaccines are safe and should be effective even for people with advanced cancer.
Delays in screening, diagnosis and treatment could lead to poorer outcomes.
Data from a large COVID-19 and cancer registry also showed that hydroxychloroquine plus azithromycin is associated with higher mortality.
Cancer type, stage and treatment appear to affect the likelihood of poor outcomes.
Those with blood cancers or lung cancer fared poorly in the first U.S. study of the new coronavirus n people with cancer.
The Lung Cancer Foundation of America has issued a work-in-progress advisory on the steps patients and their doctors should take.
A study out of China found cancer patients had a higher coronavirus risk, possibly because of hospital visits.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.